This inventor holds 1 USPTO granted patent. Top assignees: Emisphere Technologies, Inc., Novartis Ag. Active years: 2008.
Company Filing History:


Years Active: 2008
Title: Mosise Azria: Innovator in Active Agent Delivery Systems
Introduction
Mosise Azria is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of active agent delivery systems, particularly through his innovative patent work. His research focuses on enhancing the efficacy of delivery agents, which has implications for various applications in pharmaceuticals and biotechnology.
Latest Patents
Mosise Azria holds a patent for "Disodium salts, monohydrates, and ethanol solvates for delivering active agents." This patent reveals that the disodium salt of certain delivery agents demonstrates surprisingly greater efficacy for delivering active agents compared to the corresponding monosodium salt. Additionally, Azria's research indicates that these disodium salts can form solvates with ethanol and hydrates with water, which enhances their effectiveness in delivering active compounds.
Career Highlights
Throughout his career, Azria has worked with prominent companies in the pharmaceutical industry. He has been associated with Emisphere Technologies, Inc. and Novartis AG, where he has contributed to the development of innovative solutions in drug delivery systems. His work has been instrumental in advancing the understanding of how different salts can impact the delivery of active agents.
Collaborations
Mosise Azria has collaborated with notable professionals in his field, including William Elliot Bay and Rajesh K Agarwal. These collaborations have enriched his research and have led to advancements in the efficacy of delivery systems.
Conclusion
Mosise Azria's contributions to the field of active agent delivery systems are significant and impactful. His innovative patent work and collaborations with industry leaders highlight his role as a key figure in advancing pharmaceutical technologies. His research continues to pave the way for more effective drug delivery solutions.